Form 8-K - Current report:
SEC Accession No. 0001372514-24-000121
Filing Date
2024-11-08
Accepted
2024-11-08 07:01:54
Documents
14
Period of Report
2024-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20241108.htm   iXBRL 8-K 25809
2 EX-99.1 ex991-pressreleaseseptembe.htm EX-99.1 115956
  Complete submission text file 0001372514-24-000121.txt   280412

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20241108.xsd EX-101.SCH 1800
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20241108_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20241108_pre.xml EX-101.PRE 13058
16 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20241108_htm.xml XML 2814
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 241437964
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)